Learn More
Prolonged neutropenia is a major risk factor for invasive fungal infection (1-6). The incidence among neutropenic patients with cancer who are receiving intensive cytotoxic therapy ranges from 2% to(More)
PURPOSE To analyze the long-term outcome in terms of nonrelapse mortality (NRM), relapse rate (RR), progression-free survival (PFS), and overall survival (OS) in patients with angioimmunoblastic(More)